Centre Hospitalo-Universitaire de Montpellier, Service Médecine Psychologique de l'Enfant et de l'Adolescent, Montpellier, Hérault, France.
INSERM U 1018, CESP, Developmental Psychiatry/ADHD and Emotional Disorders, Villejuif, Île-de-France, France.
BMC Psychol. 2022 Nov 22;10(1):273. doi: 10.1186/s40359-022-00984-5.
Irritability is common in children and adolescents with Attention Deficit Hyperactivity Disorder (ADHD), Oppositional Defiant Disorder (ODD) and with anxiety/depressive disorders. Although youth irritability is linked with psychiatric morbidity, little is known regarding its non-pharmacological treatments. Developing non-pharmacological treatments for children with severe, chronic irritability is an important target for clinical research. To achieve this goal, we will test the benefits of parent-focused therapies in reducing irritability. The aim of the study is to compare Parent Management Training (PMT) and Non-Violent Resistance Training (NVR) programs with treatment-as-usual (TAU) on the improvement of irritability in children and adolescents with a baseline Parent-rated Affective Reactivity Index of 4 or higher, in the context of ADHD and other emotional and behavioural disorders. Additionally, we will assess (i) improvement of irritability at different times and according to different informants (parents, children, clinicians); (ii) improvement of parental strategies; and (iii) acceptability of the interventions, exploring possible mechanisms of the therapeutic effect.
Two hundred and seventy participants between 6 and 15 years with ADHD and other emotional and behavioural disorders will be recruited and randomly assigned with their parents to the PMT, NVR, and TAU groups. PMT and NVR programs have 10 online sessions and two booster sessions at 1 and at 3 months. The primary outcome measure is the change from baseline at 3 months after completion of the program of the Clinician-rated Affective Rating Scale (CL-ARI) assessed by a blind evaluator. Secondary outcome measures include the change from baseline from those scales: the CL-ARI, the Clinical Global Impression Improvement scale, the Parenting and Familial Adjustment Scales, the Child-rated Cranky thermometers and the Parent-rated ARI. We will assess the parent's expressed emotions and reflexivity during the online five-minute speech sample, clinical dimensions through the Child Behavior Checklist 6-18 and the Inventory of Callous Unemotional traits. Evaluations will be done remotely at baseline and at 1- and 3-months follow-up visits.
We expect a benefit in controlling irritability in the treatment groups. This will constitute an important achievement in promoting parental support programs in the treatment of irritability in the context of emotional and behavioural disorders.
gov. Number: NCT05528926. Registered on the 2nd of September, 2022.
易激惹是儿童和青少年注意缺陷多动障碍(ADHD)、对立违抗性障碍(ODD)和焦虑/抑郁障碍的常见症状。尽管青少年易激惹与精神疾病有关,但对于其非药物治疗方法知之甚少。为患有严重、慢性易激惹的儿童开发非药物治疗方法是临床研究的一个重要目标。为了实现这一目标,我们将测试以父母为中心的治疗方法在减轻易激惹方面的益处。该研究的目的是比较父母管理培训(PMT)和非暴力抵抗训练(NVR)与常规治疗(TAU)对 ADHD 和其他情绪和行为障碍儿童和青少年的父母评定的情感反应性指数(Parent-rated Affective Reactivity Index)基线为 4 或更高的易激惹程度的改善。此外,我们将评估(i)不同时间和不同信息提供者(父母、儿童、临床医生)的易激惹改善情况;(ii)父母策略的改善;(iii)干预措施的可接受性,探索治疗效果的可能机制。
将招募 270 名 6 至 15 岁患有 ADHD 和其他情绪和行为障碍的参与者,并将其父母随机分配到 PMT、NVR 和 TAU 组。PMT 和 NVR 项目有 10 节在线课程和 2 节强化课程,分别在 1 个月和 3 个月后进行。主要结局指标是在完成方案后 3 个月内由盲法评估者评估的临床医生评定的情感评定量表(CL-ARI)的基线变化。次要结局指标包括从基线变化的那些量表:CL-ARI、临床总体印象改善量表、育儿和家庭调整量表、儿童评定的暴躁温度计和父母评定的 ARI。我们将在在线的五分钟演讲样本中评估父母的表达情感和反射性,通过儿童行为检查表 6-18 和冷酷无情特质问卷评估临床维度。评估将在基线和 1 个月和 3 个月的随访访问时远程进行。
我们预计治疗组在控制易激惹方面会有获益。这将是在情绪和行为障碍背景下促进父母支持计划治疗易激惹方面的重要成就。
gov. 编号:NCT05528926。于 2022 年 9 月 2 日注册。